1. The regulation of the synthesis of phosphoenolpyruvate carboxykinase (GTP) (EC 4.1.1.32) in epididymal adipose tissue, liver and kidney in vivo was studied immunochemically. 2. Phosphoenolpyruvate carboxykinase (GTP) synthesis in adipose tissue is increased by starvation, diabetes and noradrenaline, and decreased by re-feeding and insulin. These changes were also seen in adrenalectomized rats and are qualitatively similar to those observed for the liver enzyme. This indicates the involvement of cyclic AMP as an inducer and insulin as a de-inducer in the regulation of phosphoenolpyruvate carboxykinase (GTP) in both tissues. (Induction and de-induction are defined as selective increase and decrease respectively in the rate of enzyme synthesis, regardless of the mechanism involved.) 3. Adrenalectomy had little effect on phosphoenolpyruvate carboxykinase (GTP) synthesis in liver and kidney, but increased the synthesis rate of the adiposetissue enzyme. Starvation and adrenalectomy had additive effects in increasing the synthesisrate ofadipose-tissue phosphoenolpyruvate carboxykinase (GTP). In adrenalectomized diabeticrats glucocorticoids increased phosphoenolpyruvate carboxykinase (GTP) synthesis in liver and kidney while decreasing enzyme synthesis in adipose tissue. De-induction of adipose tissue phosphoenolpyruvate carboxykinase (GTP) is therefore regulated independently by glucocorticoids and insulin. 4. Although liver, kidney and adiposetissue phosphoenolypyruvate carboxykinases (GTP) are seemingly identical, there is an apparent tissue-specific differentiation in regulatory systems for the enzyme.
Phosphoenolpyruvate carboxykinase (GTP) (EC 4.1.1.32) is present in the liver, kidney cortex and epididymal adipose tissue of the rat. Its physiological function in all these three tissues was described previously (Scrutton & Utter, 1968; lynedjian et al., 1975; Hopgood et al., 1973) . In each ofthese tissues the cytosolic forms ofthe enzyme share similar catalytic and immunological properties (Ballard & Hanson, 1969; Longshaw &Pogson, 1972; Hopgood et al., 1973; lynedjian et al., 1975 ), yet the hormonal regulation of their activities in vivo varies. This phenomenon indicates an apparent differentiation not only in the physiological regulation of phosphoenolpyruvate carboxykinase activity, but also in the mechanism of hormone action.
The glucocorticoids are known to affect the activity of phosphoenolpyruvate carboxykinase in all three tissues. In the liver they increase the activity and synthesis rate of the enzyme slightly, compared with cyclic AMP, and their effect is most apparent in diabetic animals or in liver-derived cells (Gunn et al., 1975a,b) . Under most conditions in vivo, the effect of glucocorticoids on hepatic phosphoenolpyruvate carboxykinase is masked by enhanced insulin release, which subsequently decreases the rate of enzyme synthesis (Gunn et al., 1975a) . In contrast both the activity and synthesis rate of the enzyme in the renal cortex are markedly increased by glucocorticoids (lynedjian et al., 1975; Gunn et al., 1975a) and do not appear to be directly affected by insulin (Kamm et al., 1974; lynedjian et al., 1975) .
Insulin and glucocorticoids are also important in the regulation of phosphoenolpyruvate carboxykinase in adipose tissue. Adrenalectomy, starvation and diabetes all cause an increase in enzyme activity in this tissue, whereas injection of either insulin or glucocorticoid into adrenalectomized-diabetic animals decreases the activity of phosphoenolpyruvate carboxykinase (Reshef et al., 1969a (Reshef et al., ,b, 1970 . Therefore, in contrast with both the liver and kidney enzyme, phosphoenolpyruvate carboxykinase activity in adipose tissue appears to be decreased by both I insulin and glucocorticoid acting independently. Hopgood et al. (1973) have shown that, when starved animals are re-fed, there is a decrease in the synthesis rate of adipose tissue phosphoenolpyruvate carboxykinase. This is circumstantial evidence indicating that insulin regulates this enzyme, as it does the liver enzyme, through changes in synthesis rate. In the present paper the separate effects of insulin and glucocorticoids on the synthesis rate of phosphoenolpyruvate carboxykinase in adipose tissue, liver and kidney have been investigated more thoroughly in vivo in adrenalectomized and diabetic animals.
Experimental
Male Wistar rats (6-8 weeks, old) were used throughout the experiments. Adrenalectomized animals were maintained on 1 % (w/v) NaCl and used 4-6 days after the operation. Diabetes was induced by subcutaneous injection of 18.5 mg ofalloxan/100 g body wt. Only animals exhibiting marked glucosuria were used in the study. Bilateral adrenalectomy was performed on diabetic rats 3 days after alloxan treatment and the adrenalectomized-diabetic animals were used 3 or 4 days later provided that a high glucosuria was still evident.
Cortisol 21-phosphate (disodium salt) and noradrenaline were from Sigma Chemical Co., St. Louis, MO, U.S.A., and triamcinolone acetonide (9a-fluoro- (Ballard & Hanson, 1969; Hopgood et al., 1973; lynedjian et al., 1975) (Ballard & Hanson, 1969) . One unit of enzyme activity catalyses the fixation of Igmol of NaH14CO3/min at 37°C. Radioactivity incorporated into phosphenolpyruvate carboxykinase, isolated as an antigen-antibody precipitate, and into total cytosol protein was determined as described (Hopgood et al., 1973) . Synthesis rates for phosphoenolpyruvate carboxykinase are expressed both as the radioactivity incorporated into the enzyme/30 min per mg of tissue and as the percentage of cytosol protein synthesis.
Results
Phosphoenolpyruvate carboxykinase activity in the epididymal adipose tissue of the rat is increased by injection of adrenaline or noradrenaline into intact animals, increased by bilateral adrenalectomy, and decreased by injection of cortisol or triamcinolone (Reshef et al., 1970; . These changes are due, at least in part, to changes in the synthesis rate of the enzyme (Table 1) . Further, these effects of noradrenaline and glucocorticoids on phosphoenolpyruvate carboxykinase are not due to large alterations in the rate of cytosol protein syntlhesis, for although adrenalectomy increased the incorporation of leucine into adipose-tissue proteins, the effect on the enzyme was greater (Table 1) .
This increase in the activity and synthesis rate of adipose-tissue phosphoenolpyruvate carboxykinase in adrenalectomized rats is not reflected by complementary changes in either the activity of the hepatic enzyme (Reshef et al., 1969a (Reshef et al., ,b, 1970 or the activity and synthesis rate ofthe renal enzyme (lynedjian et al., 1975) . Starvation of intact rats, however, increases both the activity and the synthesis rate of the enzyme in all three tissues (Hopgood et a!., 1973; Tilghman et al., 1974; Gunn etal., 1975a) . Therefore a comparison of the effects of glucocorticoids on the activity and synthesis rate of phosphoenolpyruvate carboxykinase in all three tissues in both adrenalectomized and starved animals might more clearly define the tissue differences in the regulation of the enzyme by glucocorticoids ( Table 2) .
As found previously (Reshef et al., 1969a,b) , the activity of phosphoenolpyruvate carboxykinase in adipose tissue is increased by starvation and adrenalectomy and further increased by a combination of both treatments. These changes are accompanied by comparable increases in the synthesis rate of the enzyme (cf. Tables 1 and 2 ). Under all threeconditions both the activity and synthesis rate of phosphoenolpyruvate carboxykinase may then be decreased by injection of triamcinolone ( (lynedjian et al., 1975; Gunn et al., 1975a) as well as adrenalectomized rats (Table 2) . Hepatic enzyme activity and synthesis rate, on the other hand, although increased by starvation, were little affected by adrenalectomy and decreased after injection of triamcinolone. We lhave previously reported (Gunn et al., 1975a ) that adminiistration of Vol. 158 glucocorticoids results in insulin release and that this is the probable cause of the decrease in the rate of hepatic enzyme synthesis seen in both fed and starved animals. Insulin given directly to diabetic rats, or the release ofinsulin mediated either by re-feeding starved animals or by triamcinolone injection, produces a rapid fall in the rate of hepatic phosphoenolpyruvate carboxykinase synthesis (Hopgood et al., 1973; Tilghman etal., 1974; Gunn et al., 1975a) . However, this effect did not appear to be as marked for the liver enzyme in starved adrenalectomized rats (Table 2) . Sin-ce the activity and synthesis rate of adiposetissue phosphoenolpyruvate carboxykinase is also decreased by insulin, re-feeding and triamcinolone (Reshef et al., 1970; Hopgood et al., 1973;  Tables 1  and 2) , we used starved, adrenalectomized rats to (Table 3 ), but as in intact animals the effect was slow in comparison with the liver (Hopgood et al., 1973) . The difference in the response of the liver enzyme to re-feeding and glucocorticoids in starved intact or adrenalectomized rats might reflect the amount of insulin secreted during the different treatments. Compared with the liver enzyme, the slower response of adipose-tissue phosphoenolpyruvate carboxykinase to re-feeding might reflect differences in insulin concentration between the portal vein and peripheral vessels. Insulin injection into diabetic rats (Table 4) causes a rapid decrease in the synthesis rate of hepatic phosphoenolpyruvate carboxykinase, but has little effect, over the first 2h of treatment, on the relative synthesis rate of the adipose-tissue enzyme.
The data in Tables 3 and 4 therefore indicate that phosphoenolpyruvate carboxykinase in both adipose tissue and liver is de-induced by insulin, that de-induction is slow in adipose tissue compared with liver, and that this effect of insulin in vivo is separate and independent of any direct effect of the glucocorticoids. On the other hand, the possibility exists that the action of glucocorticoids to decrease the synthesis rate of adipose-tissue phosphoenolpyruvate carboxykinase is mediated via insulin release (Gunn et al., 1975a) . However, the difference in the response of the enzyme in adipose tissue, liver and kidney to adrenalectomy and triamcinolone injection ( Hopgood etal., 1973) . Therefore the effect ofglucocorticoids on the apparent degradation rate of phosphoenolpyruvate carboxykinase was investigated in adipose-tissue organ culture and is reported in the accompanying paper (Meyuhas et al., 1976) .
Discussion
The cytosolic forms of phosphoenolpyruvate carboxykinase in adipose tissue, liver and kidney share similar physical, catalytic and immunochemical properties (Ballard & Hanson, 1969; Longshaw & Pogson, 1972; Hopgood etal., 1973; lynedjian etal., 1975; Meyuhas et al., 1976 The regulation of phosphoenolpyruvate carboxykinase activity in adipose tissue, liver and kidney shares certain features common to all three tissues. Thus enzyme activity and synthesis rate are increased in diabetic and starved animals (Hopgood et al., 1973; Tilghman et al., 1974 Tilghman et al., , 1975 Gunn et al., 1975a,b;  Tables 1, 2 and 4) . Characteristically, however, the regulation of phosphoenolpyruvate carboxykinase under these conditions, at least in the liver and kidney, is mediated by different primary effectors. Hepatic enzyme activity and synthesis rate are increased by glucagon, acting through cyclic AMP, and decreased by insulin (Tilghman et al., 1974 (Tilghman et al., , 1975 Gunn etal., 1975a,b) , whereas the activity and synthesis rate of renal phosphoenolpyruvate carboxykinase are not directly affected by these effectors, but by the acid-base status of the animal (Gunn et al., 1975a; Iynedjian et al., 1975) .
Evidence for a direct involvement of insulin in the regulation of adipose-tissue and liver cytosol phosphoenolpyruvate carboxykinase comes from experiments in isolated cell systems (Meyuhas et al., 1976;  Tissue Adipose Liver Kidney Time after triamcinolone (h) 0 (8) 10 (3) 24 (9) 0 (16) 10 (8) 24 (13) 0 (16) 10 (8) 24 (13) 6 0. MEYUHAS, L. RESHEF, J. M. GUNN, R. W. HANSON AND F. J. BALLARD Tilghman et al., 1975) . In both cases insulin deinduced the synthesis of the enzyme. Also in vivo, the activity and synthesis of liver and adipose-tissue enzymes are decreased by injecting insulin to diabetic rats or by re-feeding starved animals (Reshef et al., 1970; Hopgood et al., 1973; Tilghman et al., 1974 ; Tables 3 and 4) . However, in the liver the rate of de-induction of phosphoenolpyruvate carboxykinase synthesis exceeds that of the adipose tissue enzyme by about an order of magnitude (Hopgood et al., 1973 ; Tables 3 and 4) . Whether this observation has any tissue-specific regulatory significance remains to be resolved. The other striking feature is the tissue-specific response of cytosol phosphoenolpyruvate carboxykinase in all three tissues to glucocorticoids. Thus the activity and synthesis of both kidney and liver enzymes are increased by triamcinolone (Table 5; Gunn et al., 1975a; Iynedjian et al., 1975) , but the effect on the liver enzyme is small and apparent only in diabetic rats (cf. Tables 2 and 5; Gunn et al., 1975a) . Moreover removal of corticosteroids, by adrenalectomy of intact rats, has little effect on the response of the two enzymes to starvation and is only apparent in diabetic rats.
In contrast, the activity and synthesis of adiposetissue phosphoenolpyruvate carboxykinase are markedly decreased by glucocorticoids and increased by adrenalectomy. They are independent of insulin release as is indicated by the glucocorticoid effect on diabetic rats (Table 5) and by a direct effect of these hormones onadipose-tissueorganculture (Meyuhas et al., 1976) .Thistissue-specificresponseofadiposetissue to glucocorticoids may be associated with a decreased protein synthesis caused by the hormone in this tissue. Measurements of leucine concentration in the amino Table 6 . Effect oftriamcinolone on leucine concentration in amino acid pools of adipose tissue from adrenalectomized diabetic rats Adrenalectomized diabetic rats were injected subcutaneously with triamcinolone (5mg/1OOg body wt) and killed 24h later. Non-injected adrenalectomized diabetic rats served as controls. Two batches of adipose tissue from untreated rats and two batches of rats treated with triamcinolone were frozen by liquid air and homogenized with 5% (w/v) trichloroacetic acid in O.05M-sodium citrate buffer, pH 2.2, and analysed on a Beckman model 120B amino acid analyser according to the makers' instructions. Numbers in parentheses indicate the number of animals used for each batch. (Table 6 ) enable one to determine its true specific radioactivity and hence the amount incorporated into cytosol proteins. We note that the tissue concentration of free leucine is not significantly changed by triamcinolone treatment of adrenalectomized diabetic rats. Since the radioactivity in the trichloroacetic acid-soluble fraction is also not affected (results not shown), and hence the specific radioactivity of tissue leucine, it implies that corticosteroids decrease the synthesis of total cytosol proteins in adipose tissue. This is not the only metabolic activity so affected by corticosteroids in adipose tissue. Decreased glucose transport (Munck, 1962) and a decreased incorporation of [3H]uridine (0.
Meyuhas & L. Reshef, unpublished work) have been demonstrated in adipose tissues in vitro. The decreased synthesis of adipose-tissue phosphoenolpyruvate carboxykinase caused by glucocorticoids is therefore probably a resultant expression of one or all of these effects. Why the response of this enzyme to glucocorticoids is more sensitive than that of other cytosol proteins (as is evident from the change in the relative rate of its synthesis) remains to be resolved. The data reported here therefore indicate that adipose-tissue phosphoenolpyruvate carboxykinase, in contrast with the enzyme in liver and kidney, is de-induced by both glucocorticoids and insulin acting independently of one another. Enhanced insulin release after triamcinolone injection into non-diabetic animals will therefore lead to the more rapid deinduction of adipose-tissue phosphoenolpyruvate carboxykinase, evident in comparing Tables 2 and 5 , whereas a combination of adrenalectomy and starvation leads to additive effects in terms of increased enzyme activity and synthesis rate (Table 2) .
